NYHET! Abilify Maintena® (aripiprazol) 960 mg annenhver måned – Hjernenett

Disse sidene inneholder informasjon kun beregnet på helsepersonell

Du forlater nå hjernenett.no

Foreslåtte søkeord: Avflatning , Doseringsveileder , Interaksjoner , Brekspiprazol , Oppstart to injeksjoner , Antidepressiva , Bivirkninger

NYHET! Abilify Maintena® (aripiprazol) 960 mg annenhver måned

I denne videoen forteller Øistein Resell om Abilify Maintena® 960 mg som gis annenhver måned.1

Abilify Maintena® (aripiprazol) 960 mg er indisert for vedlikeholdsbehandling av schizofreni hos voksne pasienter som er stabilisert med aripiprazol.2 

For dosering- og administrasjonsguide: klikk her.

 

Les mer: bivirkningsrapportering

Les mer: Abilify Maintena®felleskatalogtekst

NO-ASMT-0006-2024.04

NO-AM2-2400011

  1. Abilify Maintena® 960 mg SPC 04/2024, 4.2.

  2. Abilify Maintena® 960 mg SPC 04/2024, 4.1.

  3. Harlin M, Yildirim M, Such P et al. A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder. CNS Drugs 2023;37:337-50.

  4. Kane JM, Sanchez R, Perry PP et al. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2012;73:617–24.

  5. Naber D, Hansen K, Forray C et al. Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia Schizophren Res 2015;168:498-504.

  6. Naber D, Baker R, Eramo A et al. Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study. Schizophr Res 2018;192:205–10.

  7. Kane JM, Zhao C, Johnsons BR et al. Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis. J Med Econ 2015;18:145–54.

  8. Abilify Maintena® 960 mg SPC 04/2024, 4.8.

Dato publisert 03.06.2024